We're taking a closer look at Align Technology today, as the chatter surrounding the stock has increased notably in the last few weeks. Today, its shares moved -7.5% compared to -0.0% for the S&P 500. Increased investor interest and volatility surrounding the stock are not reason enough to buy in -- you should first perform your own due diligence. Here are some figures that can get you started:
-
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally.
-
Align Technology has moved 33.0% over the last year compared to 13.0% for the S&P 500 -- a difference of 20.0%
-
ALGN has an average analyst rating of buy and is -14.11% away from its mean target price of $397.92 per share
-
Its trailing 12 month earnings per share (EPS) is $4.12
-
Align Technology has a trailing 12 month Price to Earnings (P/E) ratio of 83.0 while the S&P 500 average is 15.97
-
Its forward earnings per share (EPS) is $10.4 and its forward P/E ratio is 32.9
-
ALGN has a Price to Earnings Growth (PEG) ratio of 0.97, which shows the company is very undervalued compared to its earnings growth estimates.
-
The company has a Price to Book (P/B) ratio of 7.19 in contrast to the S&P 500's average ratio of 2.95
-
Align Technology is part of the Health Care sector, which has an average P/E ratio of 24.45 and an average P/B of 4.16
-
Align Technology has on average reported free cash flows of $926.76 Million over the last four years, during which time they have grown by an an average of 0.0%
